The vicious cycle where heart and kidney failure feed each other

Cardiorenal Syndrome - classification, mechanism, pathophysiology, treatment · 10:30 · Video: Armando Hasudungan · Watch at the source

In short: When the heart and kidneys fail, they don't just coexist; they actively sabotage one another. This creates a complex clinical entity known as cardiorenal syndrome (CRS), where dysfunction in one organ triggers a downward spiral of damage in the other, complicating treatment and worsening patient outcomes.

Cardiorenal syndrome (CRS) is defined by the interaction between heart and kidney systems. Because these organs are intimately connected via the circulatory system, primary dysfunction in either can induce acute or chronic secondary damage to the other. This relationship creates a 'vicious cycle' of morbidity that places a significant burden on healthcare systems and reduces patient quality of life. Both organs share common vascular risk factors like diabetes and hypertension. These overlapping conditions contribute to the development of atherosclerotic diseases.

The pathophysiology of CRS is multifaceted, involving hemodynamic changes, neurohormonal alterations, hypervolemia, hypertension, and increased venous and renal pressure. Recent research has identified deeper molecular mechanisms driving this damage, including oxidative stress, inflammation, and the activation of specific signaling pathways like the renin-angiotensin-aldosterone system (RAAS), Wnt/β-catenin, and TGF-β1/Smad. Emerging studies also point toward gut microbiota dysbiosis and noncoding RNA dysregulation as potential factors. The syndrome is also characterized by hyperuraemia and hyperuricaemia. Researchers are currently investigating how neural connections between these two organs influence disease progression.

Historically, CRS was classified into five subtypes based on which organ failed first and whether the condition was acute or chronic. However, because the underlying molecular mechanisms are still being elucidated, there is currently no single intervention proven to be universally effective for all types of CRS. Current strategies focus on managing symptoms and targeting various signaling pathways with chemical drugs, natural products, and blockers. A consensus conference in 2008 officially established the definition of this clinical entity. Because it is so complex, clinicians must use various diagnostic biomarkers to monitor its progression.

Opens the Intellect+ feed with this card first. Swipe up for the next one.

Sources

To cite this card, link to https://intellectplus.co.uk/app/science-cardiorenal-syndrome-classification-mechanism-pathophysiolog.

How we source, check and correct cards: Editorial standards.

General information, not professional advice. Spotted an error? Flag the card or see corrections and complaints.

Intellect Plus is a visual educational discovery platform for exploring fascinating facts and ideas. Brain Food, Not Brain Rot. What is Intellect Plus?

Related

Finding something worth knowing…